ArticleDrugs in R&D2025

Pharmacokinetics, Pharmacodynamics, and Safety of ET-26 in Subjects with Mild to Moderate Renal Impairment.

Fan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.